Levitra vardenafil: Post-marketing study data

In a 12-week, double-blind study in 386 evaluable men with ED and dyslipidemia, Levitra significantly increased penetration rates by 79% vs. 52% for placebo, as measured by SEP2 (p<0.001). On SEP3, Le...